It has been reported that the ERK1/2 or Wnt/β-catenin signaling pathway is vital for CSC tumorigenicity and enhances the tumorigenicity of colon cancers and gastric cancer33,34. The gene discussed is MAPK3; the disease is colonic neoplasm.